A narrative review examined the use of metal-based nanomaterials, including both precious and non-precious metals, for cancer phototherapy. This type of study looks at existing research to summarize current knowledge rather than testing new treatments directly on people. The review found that these materials can potentially be used to target and treat cancer cells when combined with light therapy. Because the study was a review and did not include a specific group of patients, it did not report direct safety data or side effects from clinical trials. The authors noted that while the concept is promising, the evidence remains limited and mostly theoretical at this stage. Readers should understand that this information is not yet ready to change medical practice. More rigorous studies are required before doctors can recommend these materials for cancer treatment. Until then, patients should rely on established cancer therapies and discuss new options with their healthcare team.
Metal-based nanomaterials show promise for cancer phototherapy in reviews
Photo by National Institute of Allergy and Infectious Diseases / Unsplash
What this means for you:
Metal-based nanomaterials show promise for cancer phototherapy, but more research is needed before clinical use. More on Cancer
Isoliquiritigenin shows significant anti-ovarian cancer effects with low toxicity as a promising natural candidate for targeted therapy Review suggests isoliquiritigenin may help fight ovarian cancer
Frontiers · Jun 4, 2026
TEAS significantly reduces overall PONV risk in patients undergoing breast surgery compared to sham stimulation or routine care TEAS reduces nausea and pain for patients having breast surgery
Frontiers · Jun 4, 2026
Volume doubling time under 200 days marks all malignant nodules in 27 studies of lung cancer screening programs Nodule growth speed helps assess lung cancer risk in screening programs
Frontiers · Jun 4, 2026
Meta-analysis finds rheumatoid arthritis associated with increased thyroid cancer risk in pooled cohort data People with rheumatoid arthritis might have a higher chance of developing thyroid cancer in some groups
Frontiers · Jun 4, 2026